Structural Basis for Agonism and Antagonism for a Set of Chemically Related Progesterone Receptor Modulators-Reference-Cited by-同舟云学术

Structural Basis for Agonism and Antagonism for a Set of Chemically Related Progesterone Receptor Modulators

Published:2011-10 Issue:40 Volume:286 Page:35079-35086
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Lusher Scott J.,Raaijmakers Hans C.A.,Vu-Pham Diep,Dechering Koen,Lam Tsang Wai,Brown Angus R.,Hamilton Niall M.,Nimz Olaf,Bosch Rolien,McGuire Ross,Oubrie Arthur,de Vlieg Jacob

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference39 articles.

1. International Union of Pharmacology. LXV. The Pharmacology and Classification of the Nuclear Receptor Superfamily: Glucocorticoid, Mineralocorticoid, Progesterone, and Androgen Receptors

2. The evolution of progesterone receptor ligands

3. Progesterone receptor modulators and progesterone antagonists in women's health

4. Selective progesterone receptor modulators 1: use during pregnancy

5. Selective progesterone receptor modulators 2: use in reproductive medicine

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Vitro Human Endometrial Cells and In Vivo Rat Model Studies Suggest That Ulipristal Acetate Impacts Endometrial Compatibility for Embryo Implantation;Archives of Medical Research;2024-12

2. Endometriosis: Molecular Pathophysiology and Recent Treatment Strategies—Comprehensive Literature Review;Pharmaceuticals;2024-06-24

3. Hydroboration of vinylsilanes providing diversity-oriented hydrophobic building blocks for biofunctional molecules;Organic & Biomolecular Chemistry;2024

4. Ulipristal acetate versus levonorgestrel-releasing intrauterine system for heavy menstrual bleeding: the UCON randomised controlled trial and mechanism of action study;Efficacy and Mechanism Evaluation;2023-10

5. Clinical Efficacy, Pharmacokinetics, and Safety of the Available Medical Options in the Treatment of Endometriosis-Related Pelvic Pain: A Scoping Review;Pharmaceuticals;2023-09-18